Liraglutide has been shown in studies to cause thyroid tumors in animals, but it is not yet known if it can cause thyroid cancer in people
P.JiL.NiemoellerE.NguynPascalM
Regulatory Status and FDA Approval Timeline Current FDA Status (as of June 2026) The FDA has not approved retatrutide for any indication as of June 2026
As GLP-1 and GIP/GLP-1 medications like Ozempic , Wegovy , Mounjaro , and Zepbound continue to revolutionize medical weight loss, a troubling trend has emerged: a surge of over-the-counter supplements marketed as GLP-1 boosters or natural GLP-1 mimics. These products are being sold online and in wellness stores, often with flashy claims and influencer endorsements
Purification of rat testicular microsomal 17- Ketosteroid reductase
Effects of GLP-1 receptor agonists on bone metabolism in humans Until recently, there were no randomized controlled trials assessing the effects of GLP-1Ra on bone metabolism during the weight loss phase using standard BMD measurement sites (i.e., lumbar spine and proximal femur) [71, 72]